EKE. Yu. Kalinin

E. Yu. Kalinin

*This is an algorithmically generated author record based on publicly available information.

E. Yu. Kalinin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of the efficacy of extracorporeal blood purification in abdominal septic shock: a prospective interventional controlled study

    by S. V. Masolitin, D. N. Protsenko, M. A. Magomedov, E. M. Shifman, I. N. Tyurin, B. Z. Belotserkovskiy, L. A. Grishina, I. V. Kolerova, A. O. Bykov, A. V. Marukhov, et al.

    Introduction. The choice of extracorporeal blood purification (EBP) tactics for septic shock (SS) complicated by acute kidney injury (AKI) remains an unresolved clinical problem. The objective was to evaluate the effectiveness of various EBP approaches in SS management. Materials and methods. Three groups were included in the study: group 1 (n = 34) received conservative therapy and hemodiafiltration (CVVHDF) for urgent indications; group 2 (n = 35) received early isolated CVVHDF; group 3 (n = 32) received early combined EBP (selective plasmapheresis with CVVHDF). We conducted a comparative analysis of clinical and laboratory parameters. Results. Application of early combined EBP as part of intensive therapy by day 3 provided a significantly better stabilization of mean arterial pressure – in 37.7% of cases (p = 0.001) – compared to isolated EBP in the early (18.3%, p = 0.042) and delayed periods (12.8%, p = 0.016); reduced organ dysfunction severity (p = 0.002) compared to day 5 outcomes with early isolated EBP (p = 0.021). ICU and hospital stays were 10.5 (6.7; 15) and 21 (18; 25) days respectively, versus 15 (9.5; 20) and 24 (17.5; 27.5) days for early isolated EBP (p = 0.054 and p = 0.267), and 21 (13.2; 26) and 27.5 (22; 41) days for delayed EBP (p = 0.001 for both). Mortality was 28.1% in the combined group versus 42.9% for early isolated EBP (p = 0.112) and 58.7% for delayed EBP (p = 0.012). Conclusions. Combined EBP as part of intensive therapy enables faster hemodynamic stabilization, improves patients’ clinical status, and leads to better disease outcomes.

  • Open Access

    The role of extracorporeal blood purification in correcting intoxication markers in septic shock: a prospective interventional controlled study

    by S. V. Masolitin, D. N. Protsenko, M. A. Magomedov, E. M. Shifman, I. N. Tyurin, B. Z. Belotserkovskiy, L. A. Grishina, I. V. Kolerova, A. O. Bykov, A. V. Marukhov, et al.

    Introduction. The use of extracorporeal blood purification (EBP) in septic shock (SS) complicated by acute kidney injury (AKI) remains a con troversial topic.The objective was to evaluate the effectiveness of EBP methods in patients with abdominal SS complicated by AKI.Materials and methods. Group 1 included 34 patients who received continuous veno-venous hemodiafiltration (CVVHDF) as emergency therapy. Group 2 consisted of 35 patients who underwent early isolated CVVHDF. Group 3 comprised 32 patients who received early combined EBP (selec tive plasma filtration + CVVHDF).Results. Combined EBP from day 1 to day 5 of therapy demonstrated a reduction in C-reactive protein from 223.5 to 140.9 mg/L (p = 0.001; −37.1%) compared to group 2 (219.7 to 179.2 mg/L; p = 0.004; −18.4%) and group 1 (214.5 to 189.3 mg/L; p = 0.772; −11.7%), as well as a decrease in interleukin-6 from 242.8 to 70.3 pg/mL (p = 0.001; −71.1%) vs. group 2 (233.7 to 123.4 pg/mL; p = 0.003; −47.2%) and group 1 (247.4 to 184.3 pg/mL; p = 0.512; −25.5%). Tumor necrosis factor levels decreased from 20.1 to 4.6 pg/mL (p = 0.001; −77.1%) in group 3, while group 2 showed a reduction from 19.4 to 11.9 pg/mL (p = 0.001; −38.7%) and group 1 exhibited minimal change (21.4 to 20.5 pg/mL; p = 0.525; −4.2%). Cystatin-C levels in group 3 decreased from 1.45 to 0.85 µg/mL (p = 0.048; −41.4%), whereas group 2 showed a slight reduction (1.6 to 1.5 µg/mL; p = 0.997; −6.3%) and group 1 demonstrated an increase (1.5 to 1.9 µg/mL; p = 0.027; +22.7%).Conclusions. Combined EBP significantly reduces inflammatory markers and improves kidney function compared to isolated renal replacement therapy, both in the early and delayed periods.

  • Experience with selective plasmosorption of cfDNA/NETs in a patient with severe acute pancreatitis (case report)

    by S.V. Masolitin, D.N. Protsenko, M.A. Magomedov, E.M. Shifman, L.A. Grishina, I.V. Kolerova, E.T. Abdullin, N.S. Pokrovsky, D.V. Losev, E.YU. Kalinin

    Background. Modality, timing and duration of extracorporeal detoxification (ECD) in patients with severe acute pancreatitis are a controversial and unsolved problem. Objective. To evaluate safety, clinical and laboratory effectiveness of selective plasmosorption (SP) in a patient with severe acute pancreatitis. Material and methods. A 34-year-old patient presented with severe acute pancreatitis complicated by enzymatic shock. Clinical, laboratory and instrumental diagnostic methods were performed. Cell-free deoxyribonucleic acid (cfDNA) SP was used together with standard intensive therapy. The main laboratory parameters were compared. Results. SP significantly reduced the markers of systemic endogenous intoxication: CRP from 64.3 to 29.5 mg/l (54.12%) by the 4th day; leukocytes from 16.2 to 7.8∙109/l (51.85%); IL-1 from 224.1 to 16.7 pg/ml (92.55%); IL-6 from 423.4 to 84.4 pg/ml (80.1%); TNF-α from 627.2 to 102.6 pg/ml (83.64%); cfDNA from 2270 to 10 ng/ml (99.56%), band neutrophils from 18% to 11% (33.89%) by the 7th day. Acid-base state normalized by the 3rd day (pH from 7.15 to 7.31, BE from –11.2 to –2.6, lactate from 4.9 to 1.4 mmol/l). SOFA scores decreased from 6 to 1 point by the 7th day. Conclusion. SP of cfDNA quickly normalizes the main clinical and laboratory parameters, as well as markers of systemic endogenous intoxication.

  • Open Access

    Selective plasmofiltration in the treatment of patients with abdominal septic shock: a prospective interventional controlled study

    by S. V. Masolitin, Denis N. Protsenko, M. A. Magomedov, E. M. Shifman, I. N. Tyurin, L. A. Grishina, I. V. Kolerova, A. O. Bykov, A. V. Marukhov, N. V. Chubchenko, et al.

    INTRODUCTION: The choice of tactics for the use of extracorporeal detoxification in the form of indications and modality of procedures in patients with abdominal septic shock (SS) remains an unsolved problem. OBJECTIVES: To evaluate the effect of selective plasmofiltration (SPF) as part of complex intensive therapy on the dynamics of markers of systemic inflammatory response syndrome, the severity of the condition and disease outcomes in patients with abdominal SS. MATERIALS AND METHODS: The study included 85 patients with the clinical picture of abdominal SS complicated by acute kidney injury. Group 1 (23 patients) received combined detoxification: SPF and continuous renal replacement therapy (CVVHDF). Group 2 (62 patients) received isolated CVVHDF. A comparative analysis of the main clinical and laboratory parameters and treatment outcomes was performed between the groups. RESULTS: The use of combined detoxification made it possible to reduce markers of systemic endogenous intoxication: C-reactive protein from 225.4 (211; 248.4) to 210.5 (180.39; 230.18) mg/l by the 3rd day of therapy (6.6 %; p = 0.0016), by the 5th–7th–10th days 156.17 (110.67; 180.62), 87 (74.5; 94.1), 62.2 (45.7; 71), respectively (30.7–61.4–72.4 %; p = 0.044; p = 0.0001; p = 0.0001); interleukin-6 demonstrated a decrease of 12.2 % by the 2nd day (p = 0.017) and 35.5, 39.4, 45.7 and 52.4 % by the 3rd–5th–7th–10th days of therapy, respectively (p = 0.022; p = 0.009; p = 0.0018; p = 0.0001); leukocytes from 19.7 (17.7; 22.4) to 17.25 × 109/l (14.65; 19.15) by the 3rd day (12.4 %; p = 0.00045), and 10.9 (9.3; 14.1) by the 10th day (44.7 %; p = 0.00048). Severity of organ dysfunction (SOFA) from 6 (4; 6) on the 1st day to 4 (3; 5) points by the 3rd day of therapy (p = 0.026). A significant difference in survival was obtained (p = 0.037). CONCLUSIONS: Combined detoxification consisting of SPF and CVVHDF allows for rapid normalization of laboratory markers of systemic inflammatory response syndrome and improves patient survival.

  • Open Access

    Evaluation of the use of combined extracorporeal detoxification in patients with severe acute pancreatitis: a retrospective cohort study

    by S. V. Masolitin, Denis N. Protsenko, I. N. Tyurin, T. G. Kim, M. A. Magomedov, L. A. Grishina, Е. Б. Гельфанд, O. V. Ignatenko, A. O. Bykov, E. Y. Kalinin, et al.

    INTRODUCTION: Morbidity and mortality of severe acute pancreatitis (SAP) remains high. The most important direction of therapy is the relief of endotoxicosis. The use of extracorporeal detoxification (ECD) is a debatable problem. OBJECTIVE: Improving the results of treatment of patients with SAP, through the use of ECD methods. MATERIALS AND METHODS: The study included 25 patients. Group 1: ECD included 9 patients who used standard therapy with selective hemoperfusion (HP) and continuous veno-venous hemofiltration (CVVHF). Group 2 (control) 16 patients received standard therapy. We performed a comparative analysis of the main clinical and laboratory parameters and treatment outcomes between the groups. RESULTS: The use of ECD allowed to reduce the number of leukocytes from 14.9 to 8.6 × 109/l by 5 days of therapy in group 1, and from 17.6 to 16.1 × 109/l in group 2, respectively. The dynamics of CRP concentration from 1 to 5 days changed from 315.6 to 184.6 mg/ml and 274.2 to 352.9 mg/ml in groups 1 and 2, respectively. The level of PCT concentration on days 1–5 decreased from 4.5 to 2.1 ng/ml and 3.95 to 6.9 ng/ml in groups 1 and 2, respectively. The concentration of IL-6 decreased from 1624.3 to 914.3 pg/ml in group 1, and increased from 1529.8 to 1861.8 pg/ml in group 2, respectively. The dynamics of pH in group 1 was from 7.14 to 7.4 by the 5th day of therapy and 7.13 to 7.22 in group 2, respectively. SOFA by day 5 in group 1 was 4 points and 11 points in group 2, respectively. CONCLUSIONS: The use of HP and CVVHF in complex intensive care is accompanied by a significant regression of markers of endogenous intoxication, resolution of the acid-base state and reduces the severity of organ dysfunction and the risk of adverse outcomes, compared with standard treatment.


  • Open Access

    Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury

    by S. V. Masolitin, M. A. Magomedov, T. G. Kim, I. N. Tyurin, V. M. Smetanina, E. Yu. Kalinin, D. N. Protsenko

    Применение селективной гемосорбции и гемодиафильтрации у пациента с рабдомиолизом токсического генеза, осложненным острым почечным повреждением


  • Open Access

    Evaluation of volemic status during combined extracorporeal detoxification in patients with severe acute pancreatitis: a retrospective observational study

    by S. V. Masolitin, Denis N. Protsenko, I. N. Tyurin, O. A. Mamontova, M. A. Magomedov, T. G. Kim, L. A. Grishina, A. V. Yaralyan, A. Y. Popov, E. Y. Kalinin

    INTRODUCTION: The morbidity and mortality of severe acute pancreatitis (SAP) remains high. Intensive therapy aimed at stopping hypovolemia, systemic endotoxicosis is a debatable problem. OBJECTIVE: Improving treatment results in patients with SAP by assessing the dynamics of volumetric criteria and the degree of fluid therapy (FT). MATERIALS AND METHODS: The study included 25 patients. First, study group of 9 patient, used standard therapy in conjunction with selective hemoperfusion and continuous veno-venous hemofiltration. Second, control group of 16 patients, who received standard intensive care. FT in the groups was 2.5–3.5 ml/kg/h. Volemic parameters were measured by transpulmonary thermodilution. The central venous pressure and the diameter of the vena cava inferior were assessed. Comparative analysis was performed between two groups. RESULTS: FT in the amount of 58.7 (52.4–59.4) ml/kg/day in group 1, and 58.3 (54.2–61.4) ml/kg/day in group 2 in the first day, up to 83.9 (72.4–86.1) and 79.3 (72.4–84.1) ml/kg/day, was observed by day 3 (p < 0.05), according to the results of transpulmonary thermodilution. From the 1st to the 3rd day, Global end-diastolic volume index increased from 345 (328–412) to 648 (590–690) ml/m2 in group 1, and from 375 (348–413) to 654 (599–701) ml/m2 in group 2 (p < 0.05). Intrathoracic blood volume index increased from 440 (420–510) to 780 (750–40) ml/m2 in group 1 and 430 (417.5–465) to 750 (665–780) ml/m2 in group 2 (p < 0.05). Extravascular lung water index and pulmonary vascular permeability index by 5 days in group 2 increased by 1.8 — 11 (10.5–11.8) and 2.2 times — 6.5 (5.75–7), respectively (p < 0.05). CONCLUSIONS: FT 3.5 ml/kg/h, reaches isovolemia by the 3rd day of therapy. The use of extracorporeal detoxification methods in complex therapy is accompanied by an improvement in clinical and laboratory parameters.